Kawasaki disease: Novel insights into etiology and genetic susceptibility

Annual Review of Medicine

Volumn 62, Issue , 2011, Pages 69-77

  Rowley, Anne H ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

coronary artery aneurysms; IgA; intracytoplasmic inclusion bodies; ITPKC; pediatrics; vasculitis

Indexed keywords

BACTERIAL TOXIN; IMMUNOGLOBULIN A; INOSITOL 1,4,5 TRIPHOSPHATE 3 KINASE C; INOSITOL TRISPHOSPHATE 3 KINASE; MERCURY; SUPERANTIGEN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ARTICLE; ASIAN; AUTOIMMUNITY; CAUCASIAN; CELL INCLUSION; ELECTRON MICROSCOPY; ENVIRONMENTAL EXPOSURE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; INFECTION; INNATE IMMUNITY; ITPKC GENE; JAPANESE; MERCURIALISM; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATHOGENESIS; PLASMA CELL; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; VASCULITIS;

ANTIBODIES; AUTOIMMUNE DISEASES; COMMUNICABLE DISEASES; CORONARY ARTERY DISEASE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HAZARDOUS SUBSTANCES; HUMANS; IMMUNOGLOBULIN A; INCLUSION BODIES; JAPAN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); POLYMORPHISM, GENETIC; PREVALENCE; UNITED STATES;

EID: 79551587929     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev-med-042409-151944     Document Type: Article

References (47)

1. Newburger JW, Takahashi M, Burns JC, et al. 1986. The treatment of Kawasaki syndrome with intravenous gamma globulin. N. Engl. J. Med. 315:341-47
2. Newburger JW, Sleeper LA, McCrindle BW, et al. 2007. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N. Engl. J. Med. 356:663-75
3. Kawasaki T. 1967. [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. Arerugi 16:178-222. In Japanese
4. Patriarca PA, Rogers MF, Morens DM, et al. 1982. Kawasaki syndrome: association with the application of rug shampoo. Lancet 2:578-80
5. Ohga K, Yamanaka R, Kinumaki H, et al. 1983. Kawasaki disease and rug shampoo. Lancet 1:930
6. Nakamura Y, Yashiro M, Uehara R, et al. 2008. Increasing incidence of Kawasaki disease in Japan: nationwide survey. Pediatr. Int. 50:287-90
7. Bell DM, Brink EW, Nitzkin JL, et al. 1981. Kawasaki syndrome: description of two outbreaks in the United States. N. Engl. J. Med. 304:1568-75
8. Dean AG, Melish ME, Hicks R, Palumbo NE. 1982. An epidemic of Kawasaki syndrome in Hawaii. J. Pediatr. 100:552-57
9. Mason W, Jordan S, Sakai R, Takahashi M. 1988. Lack of effect of gamma-globulin infusion on circulating immune complexes in patients with Kawasaki syndrome. Pediatr. Infect. Dis. J. 7:94-99
10. Rowley AH, Eckerley CA, Jack HM, et al. 1997. IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. J. Immunol. 159:5946-55
11. Holman RC, Belay ED, Christensen KY, et al. 2010. Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007. Pediatr. Infect. Dis. J. 29:483-88
12. Yanagawa H, Nakamura Y, Kawasaki T, Shigematsu I. 1986. Nationwide epidemic of Kawasaki disease in Japan during winter of 1985-86. Lancet 2:1138-39
13. Rowley AH, Baker SC, Orenstein JM, Shulman ST. 2008. Searching for the cause of Kawasaki disease- cytoplasmic inclusion bodies provide new insight. Nat. Rev. Microbiol. 6:394-401
14. Lin CY, Lin CC, Hwang B, Chiang B. 1992. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. J. Pediatr. 121:924-26
15. Choi IH, Chwae YJ, Shim WS, et al. 1997. Clonal expansion of CD8+ T cells in Kawasaki disease. J. Immunol. 159:481-86
16. Rowley AH, Shulman ST, Spike BT, et al. 2001. Oligoclonal IgA response in the vascular wall in acute Kawasaki disease. J. Immunol. 166:1334-43
17. Lee HH, Shin JS, Kim DS. 2009. Immunoglobulin V(H) chain gene analysis of peripheral blood IgM-producing B cells in patients with Kawasaki disease. Yonsei. Med. J. 50:493-504
18. Rowley AH, Shulman ST, Garcia FL, et al. 2005. Cloning the arterial IgA antibody response during acute Kawasaki disease. J. Immunol. 175:8386-91
19. Abe J, Kotzin BL, Jujo K, et al. 1992. Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc. Natl. Acad. Sci. USA 89:4066-70
20. Abe J, Kotzin BL, Meissner C, et al. 1993. Characterization of T cell repertoire changes in acute Kawasaki disease. J. Exp. Med. 177:791-96
21. Curtis N, Zheng R, Lamb JR, Levin M. 1995. Evidence for a superantigen mediated process in Kawasaki disease. Arch. Dis. Child 72:308-11
22. Pietra BA, De Inocencio J, Giannini EH, Hirsch R. 1994. TCR V beta family repertoire and T cell activation markers in Kawasaki disease. J. Immunol. 153:1881-88
23. Sakaguchi M, Kato H, Nishiyori A, et al. 1995. Characterization of CD4+ T helper cells in patients with Kawasaki disease (KD): preferential production of tumour necrosis factor-alpha (TNF-alpha) by V beta 2- or V beta 8- CD4+ T helper cells. Clin. Exp. Immunol. 99:276-82
24. Mancia L, Wahlstrom J, Schiller B, et al. 1998. Characterization of the T-cell receptor V-beta repertoire in Kawasaki disease. Scand. J. Immunol. 48:443-49
25. Leung DY, Meissner HC, Fulton DR, et al. 1993. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 342:1385-88
26. Leung DY, Meissner HC, Shulman ST, et al. 2002. Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. J. Pediatr. 140:742-46
27. Nagata S, Yamashiro Y, Ohtsuka Y, et al. 2009. Heat shock proteins and superantigenic properties of bacteria from the gastrointestinal tract of patients with Kawasaki disease. Immunology 128:511-20
28. Suenaga T, Suzuki H, Shibuta S, et al. 2009. Detection of multiple superantigen genes in stools of patients with Kawasaki disease. J. Pediatr. 155:266-70
29. Rowley AH, Shulman ST, Mask CA, et al. 2000. IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease. J. Infect. Dis. 182:1183-91
30. Brown TJ, Crawford SE, Cornwall ML, et al. 2001. CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J. Infect. Dis. 184:940-43
31. Rowley AH, Baker SC, Shulman ST, et al. 2004. Detection of antigen in bronchial epithelium and macrophages in acute Kawasaki disease by use of synthetic antibody. J. Infect. Dis. 190:856-65
32. Rowley AH, Baker SC, Shulman ST, et al. 2005. Cytoplasmic inclusion bodies are detected by synthetic antibody in ciliated bronchial epithelium during acute Kawasaki disease. J. Infect. Dis. 192:1757-66
33. Yang ZP, Cummings PK, Patton DL, Kuo CC. 1994. Ultrastructural lung pathology of experimental Chlamydia pneumoniae pneumonitis in mice. J. Infect. Dis. 170:464-67
34. Rowley AH, Baker SC, Shulman ST, et al. 2008. RNA-containing cytoplasmic inclusion bodies in ciliated bronchial epithelium months to years after acute Kawasaki disease. PLoS One 3:e1582
35. Onouchi Y. 2009. Molecular genetics of Kawasaki disease. Pediatr. Res. 65:46R-54R
36. Nakamura Y, Yashiro M, Uehara R, et al. 2008. Epidemiologic features of Kawasaki disease in Japan: results from the nationwide survey in 2005-2006. J. Epidemiol. 18:167-72
37. Holman RC, Curns AT, Belay ED, et al. 2003. Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics 112:495-501
38. Fujita Y, Nakamura Y, Sakata K, et al. 1989. Kawasaki disease in families. Pediatrics 84:666-69
39. Uehara R, Yashiro M, Nakamura Y, Yanagawa H. 2003. Kawasaki disease in parents and children. Acta Paediatr. 92:694-97
40. Onouchi Y, Tamari M, Takahashi A, et al. 2007. A genomewide linkage analysis of Kawasaki disease: evidence for linkage to chromosome 12. J. Hum. Genet. 52:179-90
41. Macian F. 2005. NFAT proteins: key regulators of T-cell development and function. Nat. Rev. Immunol. 5:472-84
42. Onouchi Y, Gunji T, Burns JC, et al. 2008. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat. Genet. 40:35-42
43. Burgner D, Davila S, Breunis WB, et al. 2009. A genome-wide association study identifies novel and functionally related susceptibility loci for Kawasaki disease. PLoS Genet. 5:e1000319
44. Burns JC, Shimizu C, Shike H, et al. 2005. Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease. Genes Immun. 6:438-44
45. Breunis WB, Biezeveld MH, Geissler J, et al. 2006. Vascular endothelial growth factor gene haplotypes in Kawasaki disease. Arthritis Rheum. 54:1588-94
46. Burns JC, Shimizu C, Gonzalez E, et al. 2005. Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease. J. Infect. Dis. 192:344-49
47. Biezeveld MH, Kuipers IM, Geissler J, et al. 2003. Association of mannose-binding lectin genotype with cardiovascular abnormalities in Kawasaki disease. Lancet 361:1268-70